Baruteau, 2025), reflecting on what this moment tells us about the future of metabolic medicine and how ready we are for it.First in Human Gene Editing for an Inherited Metabolic DiseaseShamima Rahman, Julien Baruteauhttps://doi.org/10.1002/jimd.70056Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic DiseaseKiran Musunuru, et alhttps://www.nejm.org/doi/10.1056/NEJMoa2504747